CPHL logo

Citi Pharma KASE:CPHL Stock Report

Last Price


Market Cap







23 Jun, 2024


Company Financials +

CPHL Stock Overview

Engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan.

CPHL fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance4/6
Financial Health6/6

Citi Pharma Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Citi Pharma
Historical stock prices
Current Share PricePK₨28.47
52 Week HighPK₨33.85
52 Week LowPK₨19.07
11 Month Change-3.82%
3 Month Change20.69%
1 Year Change36.74%
33 Year Changen/a
5 Year Changen/a
Change since IPO-8.96%

Recent News & Updates

Recent updates

Shareholder Returns

CPHLPK PharmaceuticalsPK Market

Return vs Industry: CPHL underperformed the PK Pharmaceuticals industry which returned 87.9% over the past year.

Return vs Market: CPHL underperformed the PK Market which returned 65.5% over the past year.

Price Volatility

Is CPHL's price volatile compared to industry and market?
CPHL volatility
CPHL Average Weekly Movement5.7%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement5.4%
10% most volatile stocks in PK Market8.2%
10% least volatile stocks in PK Market3.2%

Stable Share Price: CPHL has not had significant price volatility in the past 3 months.

Volatility Over Time: CPHL's weekly volatility (6%) has been stable over the past year.

About the Company

1990594Rizwan Ahmadwww.citipharma.com.pk

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. The company was founded in 1990 and is headquartered in Lahore, Pakistan.

Citi Pharma Limited Fundamentals Summary

How do Citi Pharma's earnings and revenue compare to its market cap?
CPHL fundamental statistics
Market capPK₨6.50b
Earnings (TTM)PK₨805.98m
Revenue (TTM)PK₨13.07b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CPHL income statement (TTM)
Cost of RevenuePK₨11.50b
Gross ProfitPK₨1.57b
Other ExpensesPK₨768.86m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date


Earnings per share (EPS)3.53
Gross Margin12.05%
Net Profit Margin6.17%
Debt/Equity Ratio24.1%

How did CPHL perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.